Published Papers & Misc - MORI MASAAKI

Division display  181 - 200 of about 646 ／  All the affair displays >>

  1. 森, 雅亮. 【自己免疫疾患-Preclinical Stateから発症・早期診断まで】全身性自己免疫疾患　小児リウマチ性疾患 医学のあゆみ. 2016; 258 (10): 990-998.

  2. 森, 雅亮. 【最近話題のウイルスおよび原虫感染症　今だからこそ知っておきたい感染症の日常診療】セミナー　実地医家が知っておくべき感染症の実地診療の実際　RSウイルス Medical Practice. 2016; 33 (1): 47-50.

  3. 森, 雅亮 and 三浦, 大 and 武井, 修治 and 日本小児リウマチ学会薬事委員会. 既存治療で効果不十分な急性期川崎病に対するインフリキシマブの薬事承認と使用の手引き 小児リウマチ. 2016; 7 (1): 74-77.

  4. 清水, 博之 and 菅原, 秀典 and 神垣, 佑 and 清水, 正樹 and 森, 雅亮. 高サイトカイン血症を合併したヒトメタニューモウイルス感染症の2例 日本小児科学会雑誌. 2016; 120 (6): 1000-1006.

  5. 中川, 雅生 and 土田, 尚 and 河田, 興 and 佐藤, 淳子 and 崎山, 美知代 and 平野, 慎也 and 森, 雅亮 and 中村, 秀文. 本邦における小児医薬品開発推進のための提言 日本小児科学会雑誌. 2016; 120 (10): 1453-1461.

  6. Yokota Shumpei, Kikuchi Masako, Nozawa Tomo, Kanetaka Taichi, Sato Tomomi, Yamazaki Kazuko, Sakurai Nodoka, Hara Ryoki, Mori Masaaki. 小児の全身性炎症性疾患の発病機序　川崎病、全身型若年性特発性関節炎とクリオピリン関連周期性発熱性症候群に対する抗サイトカイン単クローン性抗体に関する臨床試験から得られた知見(Pathogenesis of systemic inflammatory diseases in childhood: "Lessons from clinical trials of anti-cytokine monoclonal antibodies for Kawasaki disease, systemic onset juvenile idiopathic arthritis, and cryopyrin-associated periodic fever syndrome") Modern Rheumatology. 2015.01; 25 (1): 1-10. ( ichushi )

  7. Kizawa, T. and Nozawa, T. and Kikuchi, M. and Nagahama, K. and Okudela, K. and Miyamae, T. and Imagawa, T. and Nakamura, T. and Mori, M. and Yokota, S. and Tsutsumi, H.. Mycophenolate mofetil as maintenance therapy for childhood-onset systemic lupus erythematosus patients with severe lupus nephritis Mod Rheumatol. 2015; 25 (2): 210-214.

  8. Mori, M. and Kobayashi, R. and Kato, K. and Maeda, N. and Fukushima, K. and Goto, H. and Inoue, M. and Muto, C. and Okayama, A. and Watanabe, K. and Liu, P.. Pharmacokinetics and safety of voriconazole intravenous-to-oral switch regimens in immunocompromised Japanese pediatric patients Antimicrob Agents Chemother. 2015; 59 (2): 1004-1013.

  9. Mori, M. and Imaizumi, M. and Ishiwada, N. and Kaneko, T. and Goto, H. and Kato, K. and Hara, J. and Kosaka, Y. and Koike, K. and Kawamoto, H. and Maeda, N. and Yoshinari, T. and Kishino, H. and Takahashi, K. and Kawahara, S. and Kartsonis, N. A. and Komada, Y.. Pharmacokinetics, efficacy, and safety of caspofungin in Japanese pediatric patients with invasive candidiasis and invasive aspergillosis J Infect Chemother. 2015; 21 (6): 421-426.

  10. Masuzawa, Y. and Mori, M. and Hara, T. and Inaba, A. and Oba, M. S. and Yokota, S.. Elevated D-dimer level is a risk factor for coronary artery lesions accompanying intravenous immunoglobulin-unresponsive Kawasaki disease Ther Apher Dial. 2015; 19 (2): 171-177.

  11. Kobayashi, N. and Takezaki, S. and Kobayashi, I. and Iwata, N. and Mori, M. and Nagai, K. and Nakano, N. and Miyoshi, M. and Kinjo, N. and Murata, T. and Masunaga, K. and Umebayashi, H. and Imagawa, T. and Agematsu, K. and Sato, S. and Kuwana, M. and Yamada, M. and Takei, S. and Yokota, S. and Koike, K. and Ariga, T.. Clinical and laboratory features of fatal rapidly progressive interstitial lung disease associated with juvenile dermatomyositis Rheumatology (Oxford). 2015; 54 (5): 784-791.

  12. Kobayashi, N. and Kobayashi, I. and Mori, M. and Sato, S. and Iwata, N. and Shigemura, T. and Agematsu, K. and Yokota, S. and Koike, K.. Increased Serum B Cell Activating Factor and a Proliferation-inducing Ligand Are Associated with Interstitial Lung Disease in Patients with Juvenile Dermatomyositis J Rheumatol. 2015; 42 (12): 2412-2418.

  13. Kobayashi, I. and Mori, M. and Yamaguchi, K. and Ito, S. and Iwata, N. and Masunaga, K. and Shimojo, N. and Ariga, T. and Okada, K. and Takei, S.. Pediatric Rheumatology Association of Japan recommendation for vaccination in pediatric rheumatic diseases Mod Rheumatol. 2015; 25 (3): 335-343.

  14. Hara, R. and Miyazawa, H. and Nishimura, K. and Momoi, T. and Nozawa, T. and Kikuchi, M. and Sakurai, N. and Kizawa, T. and Shimamura, S. and Yasuda, S. and Hiromura, K. and Sada, K. E. and Kawaguchi, Y. and Tamura, N. and Takei, S. and Takasaki, Y. and Atsumi, T. and Mori, M.. A national survey on current use of mycophenolate mofetil for childhood-onset systemic lupus erythematosus in Japan Mod Rheumatol. 2015; 25 (6): 858-864.

  15. Yasuda, S. and Atsumi, T. and Shimamura, S. and Ono, K. and Hiromura, K. and Sada, K. and Mori, M. and Takei, S. and Kawaguchi, Y. and Tamura, N. and Takasaki, Y.. Surveillance for the use of mycophenolate mofetil for adult patients with lupus nephritis in Japan Mod Rheumatol. 2015; 25 (6): 854-857.

  16. Shimizu, H. and Mori, M. and Yoshimoto, N.. Clostridium difficile Infection Is More Severe When Toxin Is Detected in the Stool than When Detected Only by a Toxigenic Culture Intern Med. 2015; 54 (17): 2155-2159.

  17. Yokota, S. and Kikuchi, M. and Nozawa, T. and Kanetaka, T. and Sato, T. and Yamazaki, K. and Sakurai, N. and Hara, R. and Mori, M.. Pathogenesis of systemic inflammatory diseases in childhood: "Lessons from clinical trials of anti-cytokine monoclonal antibodies for Kawasaki disease, systemic onset juvenile idiopathic arthritis, and cryopyrin-associated periodic fever syndrome" Mod Rheumatol. 2015; 25 (1): 1-10.

  18. 加藤, 英明 and 宗佐, 博子 and 森, 雅亮 and 金子, 猛. メトロニダゾール誘発性脳症2例の症例報告および国内32例の文献的考察 感染症学雑誌. 2015; 89 (5): 559-566.

  19. 原, 拓麿 and 友野, 順章 and 森, 雅亮 and 山崎, 浩. ミトコンドリアDNA解析によって診断された日本海裂頭条虫症の1例 外来小児科. 2015; 18 (3): 370-372.

  20. 金高, 太一 and 森, 雅亮 and 横田, 俊平. 【画像診断-はじめに何をどう読むか?】全身　不明熱 小児内科. 2015; 47 (6): 776-780.

< PREV - NEXT >

To the head of this page.▲